GARDONI, FABRIZIO
GARDONI, FABRIZIO
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
Cyclase-associated protein 2 gene delivery: A potential multi-target approach for preventing synaptic failure in Alzheimer’s disease
2026 R. Stringhi, S. Pelucchi, L. D'Andrea, F. La Greca, E. Zianni, L. Targa, C. Mosconi, L. Vandermeulen, M. Ascagni, M.C. Speciani, F. Gardoni, D. Scheggia, V. Edefonti, M. Di Luca, E. Marcello
Long-term exposure to anti-GluA3 antibodies triggers functional and structural changes in hippocampal neurons
2025 M. Italia, A. Spinola, B. Borroni, M. Diluca, F. Gardoni
What's in your plate?AMPA receptors modulation at the crossroads of homeostatic and hedonic eating
2025 M. Italia, D. Scheggia, M. Diluca, F. Gardoni
Neuronal PCSK9 regulates cognitive performances via the modulation of ApoER2 synaptic localization
2025 S. Pelucchi, L.D. Dalt, G.D. Cesare, R. Stringhi, L. D'Andrea, F.L. Greca, C. Cambria, L. Vandermeulen, E. Zianni, S. Musardo, S. Roda, F. Bonacina, S. Nasini, M.G. Lupo, N. Ferri, S. Comai, F. Gardoni, F. Antonucci, D. Scheggia, M.D. Luca, G.D. Norata, E. Marcello
Frontotemporal dementia as a consequence of GRN mutations: From disease cause to models to therapies
2025 S. Salzano, C. Bertasini, S. Tavakolian Haghighi, J. Lundkvist, L.U. Wahlberg, C. Chiamulera, G.N. Vattemi, F. Gardoni, G. Paolone
Exome sequencing reveals a rare damaging variant in GRIN2C in familial late-onset Alzheimer's disease
2025 E. Rubino, M. Italia, E. Giorgio, S. Boschi, P. Dimartino, T. Pippucci, F. Roveta, C.M. Cambria, G. Elia, A. Marcinnò, S. Gallone, E. Rogaeva, F. Antonucci, A. Brusco, F. Gardoni, I. Rainero
Behavioral inflexibility through overtraining is mediated by reduced mGluR1/5 signaling capacity in the dorsolateral striatum
2025 V. Paget-Blanc, A. Cavaccini, A. Longaretti, L. Nava, M. Trusel, A. Rocchi, M. Pennuto, E. Marcello, F. Gardoni, B. Greco, R. Tonini
Arg209Lys and Gln508His missense variants in Rabphilin 3A cause pre- and post-synaptic dysfunctions at excitatory glutamatergic synapses
2025 M. Barzasi, A. Spinola, A. Costa, L. Pavinato, A. Brusco, E. Marcello, M. Diluca, F. Gardoni
Immune control of the basal ganglia network: Interleukin-17 as a key modulator of striatal synaptic plasticity
2025 A. Mancini, L. Bellingacci, J. Canonichesi, M. Sciaccaluga, A. Megaro, E. Zianni, M. De Carluccio, M. Pariano, E. Emiliano, A. Tozzi, C. Costa, T. Zelante, L. Romani, M.T. Viscomi, F. Gardoni, P. Calabresi, L. Parnetti, M. Di Filippo
An update on drug repurposing in Parkinson’s disease: Preclinical and clinical considerations
2025 M. Salvadè, M. Diluca, F. Gardoni
Anti-GluA3 autoantibodies define a new sub-population of frontotemporal lobar degeneration patients with distinct neuropathological features
2024 M. Italia, M. Salvadè, F. La Greca, E. Zianni, S. Pelucchi, A. Spinola, E. Ferrari, S. Archetti, A. Alberici, A. Benussi, E. Solje, A. Haapasalo, D. Hoffmann, K. Katisko, J. Krüger, R. Facchinetti, C. Scuderi, A. Padovani, M. Diluca, D. Scheggia, B. Borroni, F. Gardoni
Antidepressant-induced increase in GluA2 expression does not translate in changes of AMPA receptor-mediated synaptic transmission at CA3/CA1 synapses in rats
2023 E. Gerace, L. Polenzani, M. Magnani, E. Zianni, G. Stocca, F. Gardoni, D.E. Pellegrini-Giampietro, R. Corradetti
Missense variants in RPH3A cause defects in excitatory synaptic function and are associated with a clinically variable neurodevelopmental disorder
2023 L. Pavinato, J. Stanic, M. Barzasi, A. Gurgone, G. Chiantia, V. Cipriani, I. Eberini, L. Palazzolo, M. Diluca, A. Costa, A. Marcantoni, E. Biamino, M. Spada, S.M. Hiatt, W.V. Kelley, L. Vestito, S.M. Sisodiya, G. England Research Consortium, S. Efthymiou, P. Chand, R. Kaiyrzhanov, A. Bruselles, S. Cardaropoli, M. Tartaglia, S. De Rubeis, J.D. Buxbaum, D. Smedley, G.B. Ferrero, M. Giustetto, F. Gardoni, A. Brusco
Detection of TDP-43 seeding activity in the olfactory mucosa from patients with frontotemporal dementia
2023 E. Fontana, M. Bongianni, A. Benussi, E. Bronzato, C. Scialo, L. Sacchetto, A. Cagnin, S. Castriciano, E. Buratti, F. Gardoni, M. Italia, A. Schreiber, C. Ferracin, M. Fiorini, K.L. Newell, L. Cracco, H.J. Garringer, M.P. Cecchini, M. Polymenidou, A. Padovani, S. Monaco, G. Legname, B. Ghetti, B. Borroni, G. Zanusso
Intensive exercise ameliorates motor and cognitive symptoms in experimental Parkinson’s disease restoring striatal synaptic plasticity
2023 G. Marino, F. Campanelli, G. Natale, M. De Carluccio, F. Servillo, E. Ferrari, F. Gardoni, M. Emiliana Caristo, B. Picconi, A. Cardinale, V. Loffredo, F. Crupi, E. De Leonibus, M. Teresa Viscomi, V. Ghiglieri, P. Calabresi
Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19
2023 M. Mancini, S. Natoli, F. Gardoni, M. Di Luca, A. Pisani
Detrimental effects of soluble α-synuclein oligomers at excitatory glutamatergic synapses
2023 E. Ferrari, M. Salvadè, E. Zianni, M. Brumana, M. Diluca, F. Gardoni
Glutamatergic Treatments for Parkinson’s Disease
2022 F. Gardoni
Synaptic neurofilaments and GluN1-NfL interaction in experimental models of α-synucleinopathies
2022 A. Imarisio, E. Ferrari, A. Pilotto, M. Di Luca, A. Padovani, F. Gardoni
NMDA and AMPA Receptors at Synapses: Novel Targets for Tau and α-Synuclein Proteinopathies
2022 M. Italia, E. Ferrari, M. Diluca, F. Gardoni